Nimustine, a key chemotherapeutic agent, has shown promise in glioblastoma management. This high-grade brain tumor remains a challenge. Treatment options often fall short, but nimustine’s alkylating properties offer hope. Glioblastoma’s aggressive nature requires effective interventions. Patients face limited survival. Nimustine’s…

Hepatic encephalopathy (HE) presents a significant challenge in patients with liver dysfunction. Characterized by neuropsychiatric abnormalities, HE impacts cognition, behavior, and motor function. Treatment options often focus on reducing ammonia production, a key contributor to HE. The focus of this…